Construction for new £55m cell and gene manufacturing centre in Stevenage begins
November 24, 2015Manufacturing and Production Catapult, Cell Therapy Catapult, Hertfordshire, gene therapy, manufacturing, stevenage
The Government-backed Cell Therapy Catapult has begun the construction for its cell and gene therapy manufacturing centre. The construction …
FDA approves Beximco to manufacture Carvedilol for US
November 24, 2015Manufacturing and Production Bangladesh, Beximco, Carvediol, FDA, exports, generics
Beximco Pharmaceuticals has become the first Bangladeshi pharma company to receive approval for a prescription drug to be manufactured in …
Novartis and Amgen drugs signed-off by European Commission
November 24, 2015Manufacturing and Production Amgen, Entresto, European Commission, Novartis, blincyto
The European governing body, the European Commission, has approved the Novartis drug Entresto for heart failure and Amgen’s Blincyto for …
Novo Nordisk to go green by 2020
November 24, 2015Manufacturing and Production Novo Nordish, manufacturing, production, renewable energy
Novo Nordisk has announced plans to go green in the next five years by using only electricity from renewable sources …
OmniaMed UK appoints new senior management
November 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
OmniaMed has strengthened its senior management team by appointing Dr Clive Deverson as managing director and Dr Colin Griffin as …
MSD launches new antibiotic in the UK
November 23, 2015Manufacturing and Production, Research and Development
Merck (MSD) has launched the new intravenous antibiotic Zerbaxa (ceftolozane/tazobactam) in the UK, for the treatment of complicated intra-abdominal infections …
Dr Clive Deverson
November 23, 2015OmniaMed UK appoints new senior management OmniaMed strengthens its senior management team by appointing Dr Clive Deverson as Managing Director …
Take the Pharmafocus reader survey today
November 23, 2015Manufacturing and Production, Research and Development
As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …
Pfizer and Allergan confirm record $160 billion merger
November 23, 2015Manufacturing and Production, Research and Development
Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …
FDA approves Takeda’s Ninlaro for multiple myeloma
November 23, 2015Manufacturing and Production, Research and Development Takeda, myeloma
The US Food and Drug Administration (FDA) has approved Takeda’s Ninlaro (ixazomib) for use in combination with lenalidomide and dexamethasone …
Pfizer and Allergan on brink of $150 billion merger
November 23, 2015Sales and Marketing
Pfizer is reported to have secured formal board approval for a deal worth more than $150 billion to merge with …
Novartis bags two EU Cosentyx approvals
November 23, 2015Research and Development, Sales and Marketing
The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …
Horizon withdraws $1bn Depomed bid
November 20, 2015Sales and Marketing
Horizon Pharma has withdrawn its $1 billion unsolicited offer for Depomed following a block from a California court based on Horizon’s inappropriate …
European Commission approves Amgen’s cancer drug Kyprolis in combo therapy
November 20, 2015Research and Development, Sales and Marketing
The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …
Bioproject’s narcolepsy treatment recommended for European approval
November 20, 2015Research and Development, Sales and Marketing
The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bioproject’s Wakix (pitolisant) for the treatment of narcolepsy …
Biogen’s Enbrel biosimilar gets positive CHMP opinion
November 20, 2015Research and Development, Sales and Marketing
The Committee for Medicinal Products for Human Use (CHMP) today gave a positive opinion to Benepali- the first biosimilar version …
Turing boss Shkreli joins KaloBios as CEO; takes 70% of shares
November 20, 2015Medical Communications, Research and Development
KaloBios Pharmaceuticals has announced the appointment of Turing CEO Martin Shkreli as its own new CEO and his election as …
Alan Dunton appointed senior vice president at Purdue Pharma
November 20, 2015Manufacturing and Production, Medical Communications, Research and Development
Purdue Pharma LP has announced the appointment of Alan Dunton, MD, to the role of senior vice president of Research …
Lilly and Merck extend immuno-oncology collaboration
November 20, 2015Medical Communications, Research and Development Eli Lilly, Merck
Eli Lilly and Merck have announced the extension of their existing collaboration to evaluate the safety and efficacy of the …
Bayer awaits FDA decision on new contraceptive
November 20, 2015Medical Communications, Research and Development
Bayer has submitted a new drug application (NDA) to the FDA, seeking approval for LCS-16, an investigational hormonal intrauterine device …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
